This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 1.53a
Percent of heart failure patients with left ventricular systolic dysfunction prescribed ACE inhibitor or angiotensin receptor blocker at discharge, all payers, United States, 2005 |
| Population group |
2005 |
| Percent |
Standard error |
| Total |
|
82.9 |
0.4 |
| Gender |
Male |
82.4 |
0.1 |
| Female |
83.0 |
0.1 |
| Race |
White |
81.4 |
0.1 |
| Black |
85.4 |
0.1 |
| Hispanic |
82.9 |
0.3 |
| Native American |
85.8 |
1.0 |
| Asian |
81.5 |
0.6 |
| Age |
Under 65 |
86.8 |
0.1 |
| 65-74 |
81.8 |
0.1 |
| 75-84 |
80.2 |
0.1 |
| 85 and over |
78.5 |
0.2 |
Key: ACE: angiotensin converting enzyme.
Source: Centers for Medicare & Medicaid Services, Medicare Quality Improvement Organization Program.
5600 Fishers Lane Rockville, MD 20857